Managing Oral SERD Related AEs in HR+/HER2- MBC
Managing AEs With Oral SERDs for Patients With HR+/HER2- Metastatic Breast Cancer

Released: November 15, 2024

Expiration: November 14, 2025

Laura M. Spring
Laura M. Spring, MD

Activity

Progress
1
Course Completed